NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

EVP: Extracellular vesicle and particles small RNA sequencing Analytical Validation (Mt Sinai)   Add to my SOP compendium

BRD ID: 3,144

Source: CIMAC-CIDC Network Tier: SOP Number of times downloaded: 59

Description

This assay analytical validation and performance report describes the methods used to validate the isolation of extracellular vesicles (EVs) and particles from plasma, serum, and urine and their analysis by RNA sequencing with size exclusion chromatography (SEC). The document also presents data supporting the reported accuracy, precision, and analytical sensitivity and specificity of the assay, as well as the minimal RNA input amount and optimal sample storage conditions. It is used by a Cancer Immune Monitoring and Analysis Center (CIMAC) at the Icahn School of Medicine at Mount Sinai. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.htm), a Cancer Moonshot Initiative.

Documents for Download

Analytical report_EVPsmallRNAseq_11222022_Mt Sinai_508_Final.pdf [Size: 1786 KB]

Biospecimens
  • Fluid - Blood
  • Fluid - Serum
  • Fluid - Plasma
  • Fluid - Urine
Diagnoses
  • Neoplastic - Carcinoma
  • Neoplastic - Not specified
Topics
  • Analyte Extraction and Purification
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • More...